Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Attila Marcell Szasz

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
International Journal of Oncology|November 29, 2018
Oncological hyperthermia: The correct dosing in clinical applicationsSun-Young Lee, Gyula Peter Szigeti, Attila Marcell Szasz
Cancers|September 28, 2023
The Clinical Validation of Modulated Electro-Hyperthermia (mEHT)Sun-Young Lee, Gergo Lorant, Laszlo Grand, et al.
World Journal of Clinical Cases|September 2, 2022
Longitudinal changes in personalized platelet count metrics are good indicators of initial 3-year outcome in colorectal cancerZoltan Herold, Magdolna Herold, Julia Lohinszky, et al.
Biomedicines|March 28, 2024
Predictive Value and Therapeutic Significance of Somatic BRCA Mutation in Solid TumorsGyongyver Szentmartoni, Dorottya Mühl, Renata Csanda, et al.
Journal of Clinical Medicine|August 26, 2022
Does Elevated Pre-Treatment Plasma PD-L1 Level Indicate an Increased Tumor Burden and Worse Prognosis in Metastatic Colorectal Cancer?Magdolna Dank, Dorottya Mühl, Magdolna Herold, et al.
Cancers|February 15, 2022
Longitudinal Analysis of 1α,25-dihidroxyvitamin D<sub>3</sub> and Homocysteine Changes in Colorectal CancerDorottya Mühl, Magdolna Herold, Zoltan Herold, et al.
Cancers|July 27, 2022
Prolonged Exposition with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) May Provide Survival Benefit after Cytoreductive Surgery (CRS) in Advanced Primary Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal CancerMiklos Acs, Zoltan Herold, Attila Marcell Szasz, et al.
World Journal of Clinical Cases|June 6, 2022
High plasma CD40 ligand level is associated with more advanced stages and worse prognosis in colorectal cancerZoltan Herold, Magdolna Herold, Gyorgy Herczeg, et al.
Frontiers in Oncology|October 5, 2020
Quo Vadis Oncological Hyperthermia (2020)?Sun-Young Lee, Giammaria Fiorentini, Attila Marcell Szasz, et al.
Cancers|February 11, 2023
Meta-Analysis of Modulated Electro-Hyperthermia and Tumor Treating Fields in the Treatment of GlioblastomasAttila Marcell Szasz, Elisabeth Estefanía Arrojo Alvarez, Giammaria Fiorentini, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
International Journal of Oncology|November 29, 2018
Oncological hyperthermia: The correct dosing in clinical applicationsSun-Young Lee, Gyula Peter Szigeti, Attila Marcell Szasz
Cancers|September 28, 2023
The Clinical Validation of Modulated Electro-Hyperthermia (mEHT)Sun-Young Lee, Gergo Lorant, Laszlo Grand, et al.
World Journal of Clinical Cases|September 2, 2022
Longitudinal changes in personalized platelet count metrics are good indicators of initial 3-year outcome in colorectal cancerZoltan Herold, Magdolna Herold, Julia Lohinszky, et al.
Biomedicines|March 28, 2024
Predictive Value and Therapeutic Significance of Somatic BRCA Mutation in Solid TumorsGyongyver Szentmartoni, Dorottya Mühl, Renata Csanda, et al.
Journal of Clinical Medicine|August 26, 2022
Does Elevated Pre-Treatment Plasma PD-L1 Level Indicate an Increased Tumor Burden and Worse Prognosis in Metastatic Colorectal Cancer?Magdolna Dank, Dorottya Mühl, Magdolna Herold, et al.
Cancers|February 15, 2022
Longitudinal Analysis of 1α,25-dihidroxyvitamin D<sub>3</sub> and Homocysteine Changes in Colorectal CancerDorottya Mühl, Magdolna Herold, Zoltan Herold, et al.
Cancers|July 27, 2022
Prolonged Exposition with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) May Provide Survival Benefit after Cytoreductive Surgery (CRS) in Advanced Primary Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal CancerMiklos Acs, Zoltan Herold, Attila Marcell Szasz, et al.
World Journal of Clinical Cases|June 6, 2022
High plasma CD40 ligand level is associated with more advanced stages and worse prognosis in colorectal cancerZoltan Herold, Magdolna Herold, Gyorgy Herczeg, et al.
Frontiers in Oncology|October 5, 2020
Quo Vadis Oncological Hyperthermia (2020)?Sun-Young Lee, Giammaria Fiorentini, Attila Marcell Szasz, et al.
Cancers|February 11, 2023
Meta-Analysis of Modulated Electro-Hyperthermia and Tumor Treating Fields in the Treatment of GlioblastomasAttila Marcell Szasz, Elisabeth Estefanía Arrojo Alvarez, Giammaria Fiorentini, et al.
Pageof 4